Webinars
11 March 2026
The Phase 2 Endpoint Dilemma: Bridging Subjective Scales and Objective Measures in Neurodegenerative Trials
Phase 2 neurodegenerative trials are increasingly challenged by slow disease trajectories, heterogeneous patient populations, and blunt legacy endpoints that struggle to detect treatment-related change over typical study durations.
27 June 2025
Unlocking Global Oncology Success: The Strategic Advantage of Australia & Asia for U.S. Biotechs
This expert panel will explore how Australia, Taiwan, and South Korea provide a strategic advantage in conducting early, mid, and late-phase oncology trials, offering speed, cost efficiency, and global scalability.
21 May 2025
Avance Clinical Clinical Leader Solutions Expo May 2025: CRO Services – Oncology
This presentation outlines the key success factors driving high-impact oncology drug development, with a focus on translating innovative science into clinically and commercially meaningful outcomes.
14 October 2024
Clinical Leader Solutions Expo: Early-Phase Oncology Trials (CRO)
Discover an informative webinar that delves into the strategic benefits of conducting early-phase oncology clinical development across Australia and the USA.
6 August 2024
Early-Phase Oncology: Advantages in Australia & USA
Oncology has been and continues to be the leading priority in global drug development. 44% of all Phase I-III trials, current and planned, are tackling oncology. But as the push to combat cancer evolves, so too has the drug development arena. In the last decade, small and emerging biopharma has surged to the forefront of oncology development, comprising 70% of 2023 trial starts according to IQVIA Institute. With young, innovative, funding-conscious companies leading the charge, experienced trial partners are pivotal to commercial and patient success.
21 May 2024
Psychedelics in Focus: Clinical Trials, Transformations and Regulations
Join us for an informative webinar as we delve into the world of psychedelic trials and the evolving regulatory landscape surrounding these transformative therapies.
Proven industry
experience & expertise
500+
Studies in the past 5 years
450+
Experienced team members
18k+
Participants past 5 years
30
Years of CRO experience